Latest News

Event overview and recent stock performance American Financial Group (AFG) shares recently closed at $128.09, with the stock showing a 0.1% decline over the past day, a 0.9% decline over the past week, and a 6.1% decline over the past 3 months. See our latest analysis for American Financial Group. While the share price has been weaker in recent months, with a 90 day share price return of negative 6.1% and a year to date share price return of negative 5.0%, longer term total shareholder...

Zimmer Biomet Holdings recently reported past fourth-quarter 2025 results with adjusted earnings per share of US$2.42 and net sales of US$2.24 billion, both ahead of analyst expectations and supported by growth across knees, hips, and S.E.T. products. The company’s guidance for 2026, calling for revenue growth of 2.5% to 4.5% and adjusted earnings per share of US$8.30 to US$8.45, gives investors a clearer view of how its portfolio and recent innovations might shape financial performance over...

Recent share performance and current business snapshot Affiliated Managers Group (AMG) has drawn attention after recent share moves, with the stock showing a 0.6% gain over the past day, alongside declines over the week and month. The company, an investment management firm with a market value of about US$7.3b, reports annual revenue of US$2,074.4m and net income of US$716.6m from its asset management operations. See our latest analysis for Affiliated Managers Group. Recent trading paints a...

In early March 2026, Genevant Sciences and Arbutus Biopharma reached a global settlement with Moderna over alleged unauthorized use of LNP delivery technology in its COVID-19 vaccines, with Moderna agreeing to pay US$950 million upfront in July 2026 and up to an additional US$1.30 billion depending on a future appellate ruling, while also receiving a global non-exclusive license for infectious disease applications. Around the same time, Moderna reported completion of a key Phase 1...

Earlier this month, Rivian Automotive announced full trims and pricing for its new R2 mid-size electric SUV, with Performance models starting at US$57,990 in spring 2026 and lower-priced Premium and Standard variants rolling out through 2027. A key detail is that the widely anticipated approximately US$45,000 entry-level R2 will not arrive until late 2027, reshaping expectations for how quickly Rivian can reach more price-sensitive, mass-market buyers. We’ll now examine how the delayed...

Jack Henry & Associates (JKHY) is back in focus after its Financial Crimes Defender platform was added to the Independent Community Bankers of America Preferred Service Provider program, highlighting its role in fraud prevention for community banks. See our latest analysis for Jack Henry & Associates. At a latest share price of $168.77, Jack Henry & Associates has seen a 7.71% 1 month share price return but a 10.06% 3 month share price decline. Its 5 year total shareholder return of 21.27%...

Interest in Polaris (PII) has picked up after its addition to the Russell 1000 ETF, along with plans to sell its Indian motorcycle brand to Carolwood and fresh coverage from Wells Fargo. See our latest analysis for Polaris. Despite the latest headlines, momentum in Polaris stock has cooled, with a 30-day share price return of 23.38% and a year to date share price return of 24.14%, even as the 1-year total shareholder return stands at 25.31%. Recent attention around its Russell 1000 inclusion,...

Crown Castle (CCI) is back in focus after Q4 2025 earnings topped expectations, with EPS of $0.67 and revenue of $1.07b, alongside plans to sell its small cell and fiber divisions. See our latest analysis for Crown Castle. The Q4 earnings beat and the plan to sell small cell and fiber assets come after a patchy stretch. The 30 day share price return is a 3.22% decline, and the 1 year total shareholder return is an 11.27% decline, suggesting recent enthusiasm is emerging from a weaker long...

Compagnie de Saint-Gobain (ENXTPA:SGO) has drawn fresh attention after announcing an annual dividend of €2.30 per share, payable on June 10, 2026, with an ex-date of June 8 and record date of June 9. See our latest analysis for Compagnie de Saint-Gobain. The dividend announcement comes after a weaker stretch for the shares, with a 30-day share price return of 20.98% and a year to date share price return of 17.49%. This is despite the 3-year total shareholder return of 52.97% and 5-year total...

Amgen has partnered with the government run TrumpRx platform to offer deep discounts on key brand name drugs. The agreement covers major products such as Amjevita, Aimovig, and Repatha as part of a broader U.S. drug pricing initiative. The move links Amgen directly to the Most Favored Nation pricing effort aimed at improving drug affordability and access. For investors watching NasdaqGS:AMGN, this development comes with the stock trading around $366.21 and showing a 20.4% return over the...

In recent days, Sunrun reported softer expectations for near-term earnings as analysts cut forecasts and voiced concern about slower solar origination and capacity deployment, even while revenue is still expected to grow. At the same time, Sunrun remains a major force in U.S. residential battery storage, controlling roughly half of 2025 installations and about 44% of national residential storage capacity, highlighting a tension between operational leadership and financial strain. Now we’ll...

Dianthus Therapeutics recently reported an early GO decision in its Phase 3 CAPTIVATE trial of claseprubart for CIDP, after achieving 20 confirmed responders ahead of the planned interim analysis and confirming a favorable safety profile through independent DSMB review. On the heels of these clinical results, the company completed a large follow-on public equity offering of common stock and pre-funded warrants, raising roughly US$719,000,000 to support ongoing trials, commercial readiness,...

What Recent Returns Say About BorgWarner BorgWarner (BWA) has drawn investor attention after a mixed run in its share price, with a recent month decline contrasting with gains over the past 3 months, year to date, and the past year. That backdrop, alongside annual revenue of about US$14.3b and net income of US$277 million, sets the stage for a closer look at how the auto technology supplier’s current valuation compares with its recent performance. See our latest analysis for BorgWarner. At...

In March 2026, Agios Pharmaceuticals announced that the Emirates Drug Establishment approved PYRUKYND (mitapivat) as the only authorized treatment in the UAE for adult patients with both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, expanding its reach in the Gulf region via its NewBridge Pharmaceuticals partnership. This approval deepens Agios’s footprint in rare hematologic diseases across the Gulf Cooperation Council, reinforcing the importance of...

Event context and recent share performance Sonic Automotive (SAH) has drawn investor attention after a period of mixed share performance, with the stock down about 1% over the past week and roughly 9% over the past 3 months. See our latest analysis for Sonic Automotive. At a share price of $59.89, Sonic Automotive’s recent 1 day and 90 day share price declines of 1.32% and 8.8% contrast with a 1 year total shareholder return of 4.01%. This suggests that short term momentum has cooled while...

Cboe Global Markets, Inc. has announced plans to launch the Cboe IBIT Volatility Index and a new prediction markets framework, extending its VIX methodology into bitcoin and introducing three-outcome, fixed-return contracts initially tied to Mini S&P 500 Index prediction markets. By pairing a bitcoin volatility gauge with an options-style prediction market that allows partial payouts, Cboe is seeking to broaden access to outcome-based trading while aligning it with established exchange...

In March 2026, Guidewire Software reported quarterly results showing revenue of US$359.1 million and net income of US$60.11 million, alongside higher full-year guidance and accelerating annual recurring revenue growth. A key client, IAG New Zealand, also migrated its on-premises ClaimCenter system to the Guidewire Cloud Platform, underscoring growing adoption of Guidewire’s cloud-based insurance solutions. Next, we’ll explore how Guidewire’s stronger guidance and accelerating cloud...

In March 2026, Ford Motor Company announced a long-term agreement with Bread Financial to launch a co-branded Ford Rewards Visa Signature credit card and integrated installment loan program, giving Ford customers flexible financing and reward-earning options across online channels and dealerships nationwide. A distinctive aspect of this partnership is Bread Financial’s planned use of data-driven insights with Ford to refine offers and experiences across multiple customer touchpoints,...

Trevi Therapeutics (TRVI) has secured FDA alignment on its clinical plan for nalbuphine ER in IPF related chronic cough, clearing the way for two randomized, double blind, placebo controlled Phase 3 trials starting later this year. See our latest analysis for Trevi Therapeutics. That FDA alignment comes after a recent pullback, with a 7 day share price return showing a decline of 17.22% and a 90 day share price return showing a decline of 12.69%. However, the 1 year total shareholder return...

Legal scrutiny has intensified around James Hardie Industries (ASX:JHX), with an ongoing investigation and lawsuit alleging executives misled investors about inventory destocking in the key North America Fiber Cement segment. This development may potentially affect sentiment toward the stock. See our latest analysis for James Hardie Industries. At a latest share price of A$28.28, James Hardie’s short term share price pressure, including a 22.61% 1 month share price decline and 10.51% 7 day...

Check Point Software Technologies (CHKP) has been on some investors’ radar after a mixed picture in recent returns, with the stock down over the past year while still showing positive multi year total returns. See our latest analysis for Check Point Software Technologies. At a share price of US$153.65, Check Point’s recent 7 day share price return of 7% and 30 day return of 10.4% cap a weaker spell, which contrasts with its positive 3 and 5 year total shareholder returns. This suggests longer...

Coca-Cola FEMSA. de (NYSE:KOF) is back on investor radars after recent trading left the shares with a mixed return profile, including a 2.2% decline over the past day and 6.8% over the past week. See our latest analysis for Coca-Cola FEMSA. de. The recent 1-month share price return of a 13.8% decline contrasts with Coca-Cola FEMSA. de’s 90-day share price return of 3.5% and 1-year total shareholder return of 13.6%. This suggests shorter term momentum has cooled, while longer term holders have...

Syrah Resources (ASX:SYR) is back in focus after a sharp share price drop, following a US International Trade Commission decision that removed potential tariff protection against Chinese graphite anode material competitors. See our latest analysis for Syrah Resources. The latest ITC ruling and concerns about liquidity have come on top of an already weak run. A 1 day share price return of 29.17% decline has added to a 90 day share price return of 39.29% decline and a 1 year total shareholder...

In February 2026, Charles Schwab reported core net new assets of US$32.50 billion and a 9% year-over-year rise in 395,000 new brokerage accounts, alongside updated revenue guidance pointing to faster first-quarter revenue growth. Together with Schwab’s finalized acquisition of Forge Global to expand access to private markets, these figures highlight how the firm is broadening its investing platform while deepening client engagement. We’ll now examine how Schwab’s stronger February asset...